US pharmaceutical company Merck said Friday it will seek authorization of its oral drug molnupiravir for COVID-19 after it was shown to reduce the chance newly infected patients were hospitalized by 50 percent.
Oct 1, 2021
0
37
On Sept. 20, Pfizer-BioNTech announced that it's preparing to submit data to the Food and Drug Administration on the initial results of its COVID-19 vaccine study in school-age children. The move signaled a big step toward ...
Sep 29, 2021
0
3
The Wits Vaccines and Infectious Diseases Analytical (VIDA) research unit conducted the phase 1B/2A clinical trial. The findings, published in The Lancet HIV on 17 August 2021, show that the AstraZeneca COVID-19 vaccine is ...
Sep 13, 2021
0
7
Promising new data from a recent study indicates that active forms of vitamin D can inhibit the replication and expansion of COVID-19. The study's findings also suggest lumisterol, produced by a chemical reaction in the body ...
Sep 9, 2021
0
385
As part of the NIH-sponsored ACTIV-2 clinical trial for COVID-19 outpatients, preliminary data revealed that a new combination monoclonal antibody treatment reduced hospitalizations and death by 78 percent in high-risk patients. ...
Sep 1, 2021
0
19
Researchers at Vanderbilt University Medical Center (VUMC) and the Baylor College of Medicine in Houston, Texas, have taken a big step toward developing targeted treatments and vaccines against a family of viruses that attacks ...
Jul 16, 2021
0
6
With the health care community heavily focused on COVID-19 since the first quarter of 2020, there have been concerns that reporting of other infectious diseases—and the resulting data that enables them to be more effectively ...
Jul 15, 2021
0
4
A new study (the ATOMIC2 trial), presented at this year's European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) and published simultaneously in The Lancet Respiratory Medicine, shows the antimicrobial ...
Jul 10, 2021
0
3
New research presented at this year's European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) taking place online (9-12 July) shows that aspirin can reduce the risk of serious cardiovascular events such ...
Jul 8, 2021
0
1
A joint research group from KAIST and Institut Pasteur Korea has identified repurposed drugs for COVID-19 treatment through virtual screening and cell-based assays. The research team suggested the strategy for virtual screening ...
Jul 8, 2021
0
22
